At M3 Wake Research, we're invested in advancing research and dedicated to making an impact. Whether you're a sponsor looking for transformative collaborations or a CRO ready to contribute to our mission, our Business Development team is here to connect and explore possibilities. Contact us today to start the journey toward meaningful research partnerships! #ClinicalResearch #M3WakeResearch #ImpactfulResearch #ContactUs
M3 Wake Research
Pharmaceutical Manufacturing
Raleigh, North Carolina 8,975 followers
A multi-site network connecting patients to Phase I-IV trials while improving health outcomes & quality of life.
About us
M3 Wake Research is a premier clinical trial network that has been conducting studies since 1984. With over 30 years of experience, the network's subject database for clinical trial participants has substantial potential and continues to expand as we grow our network across the country. The network comprises of premier investigational sites that are fully integrated and designed to deliver superior clinical trial experiences to patients, sponsors, and CROs. M3 Wake Research offers a full range of clinical trial services, from study design to study completion, to meet the needs of global biopharmaceutical, biotechnology, medical device, and pharmaceutical industry leaders. The board-certified physicians of M3 Wake Research have successfully completed over 7,000 clinical trials with integrity, human protection, and expeditious delivery of accurate evaluable data. Experience M3 Wake Research's uncompromising approach to superior quality in planning and executing each study according to regulations. The network consistently exceeds sponsor expectations for integrity, subject enrollment, human protection, and expeditious delivery of accurate evaluable data. Choose M3 Wake Research for clinical trials that meet and exceed your expectations.
- Website
-
https://www.wakeresearch.com
External link for M3 Wake Research
- Industry
- Pharmaceutical Manufacturing
- Company size
- 201-500 employees
- Headquarters
- Raleigh, North Carolina
- Type
- Privately Held
- Founded
- 1984
- Specialties
- Phase I-IV Clinical Trial Conduct and Participant Recruitment/Retention in the Following Therapeutic Areas: Healthy Volunteer, Dermatology, Gastroenterology, Sleep Disorders, Men's/Woman's Health, Neurology, Vaccines, Pulmonology, Internal Medicine, and Psychiatry
Locations
Employees at M3 Wake Research
Updates
-
🌟 Exciting News! 🌟 We are thrilled to share that the U.S. FDA has approved Merck's CAPVAXIVE Pneumococcal 21-valent conjugate vaccine for the prevention of invasive #pneumococcal disease and pneumococcal #pneumonia in adults 18 years of age and older! At Wake Research, we are dedicated to advancing medical science and improving patient outcomes with the leadership and support of innovators like Dr. Kristen Marks & Susan Hernandez, MSN, APRN. Being part of groundbreaking research and clinical trials, such as those contributing to the development of CAPVAXIVE, underscores our commitment to public health and innovation. Congratulations to our team and all the collaborators who made this achievement possible! Together, we are shaping the future of healthcare. #WakeResearch #ClinicalTrials #FDAApproval #PneumococcalVaccine #MedicalInnovation #PublicHealth
We're proud to announce the #FDA approval of an option to help protect against invasive #pneumococcal disease and pneumococcal #pneumonia. Learn more: http://merck.us/4cjHNGR Thank you to all the clinical trial participants, investigators, physicians and many dedicated colleagues who have made this milestone possible.
-
Exciting Leadership Announcements at M3 Wake Research! We're thrilled to welcome Logan Ward as our new Chief Business Officer and Lauri Befus as Vice President of Clinical Operations to the M3 Wake Research executive team! Join us in welcoming Logan and Lauri to the team! 🎉 #Leadership #ClinicalResearch #Innovation #Healthcare #M3WakeResearch #NewAppointments
-
-
Exciting News For Healthcare Innovation! Moderna's newest RSV vaccine, mRESVIA, has now received FDA approval! M3 Wake Research is honored to have been a part of the clinical trials helping to advance RSV protection for the community. This milestone highlights our abilities and commitment to advancing medical research and improving patient care. Congratulations to the entire team and our dedicated participants across seven of our Wake Research sites who made this possible: - Carolina Institute for Clinical Research (Fayetteville, North Carolina) - Medical Center for Clinical Research (San Diego, California) - Mount Vernon Clinical Research (Atlanta, Georgia) - Multi-Specialty Research Associates (Lake City, Florida) - Pharmacology Research Institute- Los Alamitos (California) - Pharmacology Research Institute- Newport Beach (California) - Tucson Neuroscience Research (Tucson, Arizona) Together, we are making a difference to advance healthcare in the fight against respiratory diseases. #M3 #Wake #ClinicalTrials #MedicalResearch #PatientCare #FDAApproval #WakeResearch #mRNA #vaccine #moderna
We’re excited about the approval of mRESVIA® (Respiratory Syncytial Virus Vaccine) in the United States. With the approval of mRESVIA, Moderna is the first and only company in the world with two FDA-approved #mRNA #vaccine products. It is an exciting time for this new generation of vaccines and our platform’s continued impact on human health. Read more from our CEO Stéphane Bancel about this approval, and what’s next: https://lnkd.in/eHyp4KCR
-
World Vaccine Congress is only a few days away! Jag Sindhu, our Senior Director, Business Development will be representing us at the World Vaccine Congress from April 1-4! Interested in discussing clinical trial opportunities? Connect with them via App or on LinkedIn to schedule a meeting. #WorldVaccineCongress #ClinicalTrials #BusinessDevelopment
-
-
Our VP of Business Development, Ailsa, is gearing up for the World Vaccine Congress from April 1-4! Want to explore potential collaborations or partnerships? Connect with them via App or on LinkedIn to schedule a meeting and seize the opportunity to drive positive impact together. #WorldVaccineCongress #BusinessDevelopment #NetworkingOpportunity
-
-
Excited to announce that two of our team members will be attending World Vaccine Congress April 1-4! Connect with Ailsa - VP, Business Development and Jag Sindhu, Senior Director, Business Development on LinkedIn to schedule a meeting and discuss how we can collaborate towards global vaccine advancements. #WorldVaccineCongress #BusinessDevelopment #CollaborationOpportunities
-
-
Click to read our latest blog: https://lnkd.in/e2TtPCCW Join us as we delve into the intricate process of medical research, where dedication, innovation, and perseverance converge to bring hope to millions. #ClinicalTrials #MedicalResearch #Innovation #Hope
-
-
SCOPE Summit 2024 is here! Still want to connect and engage with our team? It’s not too late! Contact with us via the SCOPE meeting platform. Let’s discuss how our extensive site network, coupled with experienced Principal Investigators, can elevate and support your clinical trials. We hope to see you there. Our Participants: Ailsa Mendez-Fitzwilliam Timothy Stager Jag Sindhu Greg Watterson
-
-
As the SCOPE Summit approaches, we cordially invite Sponsors and CROs to engage with M3 Wake Research's BD team. Here's what to expect: • Discover our unique capabilities. • Explore collaboration opportunities for successful trials. • Strengthen our partnership through in-person meetings. We look forward to connecting with you and discussing how M3 Wake Research can enhance your trial success. Connect with us via the SCOPE Meeting Platform: Ailsa Mendez-Fitzwilliam Timothy Stager Jag Sindhu Greg Watterson
-